Related Articles

One Comment

  1. 1


    I don’t believe Papscreen or the Cancer Council have ever respected informed consent, we’re told we “must” or “should” screen with very little real information. IMO, some of it is misleading. We don’t see this in prostate screening where men received risk information very quickly and doctors were reminded to obtain informed consent, a double standard is clearly in place.
    I doubt Papscreen would want women to know how unlikely it is you’d get cervical cancer after one sexual encounter (or many) or your chance of benefiting from pap testing. I think they rely on our ignorance to achieve the govt-set target, their political objective.
    I knew it didn’t sound right 30 years ago when women were routinely being coerced into testing to get the Pill. Isn’t cancer screening always elective, or is it only elective for men? I was shocked when I eventually got to the facts, and this was pre-internet, it meant days in the medical library and speaking to academics. I made an informed decision as a low risk woman not to have pap testing, yet many doctors do not respect our right to say no.
    I have never agreed with paying our GPs incentive payments for pap tests, a potential conflict of interest, or with opportunistic screening, which is promoted to GPs by Papscreen. Women have a right to see their GPs without being pressured about pap testing and leaving less time to deal with the reason for their visit. I know many women who now avoid doctors due to this pressure. A rare cancer is the major focus in women’s healthcare, ignoring far more likely risks to our health.

    Cervical cancer is actually rare, always was and it was in natural decline before testing even began. 0.65% is the lifetime risk of cc. I had to wait for Dr Angela Raffle to do her research back in 2003 to get a real idea of how unlikely it is that an individual woman would benefit from pap testing, “1000 women need regular screening for 35 years to save ONE woman from cc”. Even worse, the lifetime risk of referral for colposcopy (and usually some sort of biopsy) is a whopping 77% here in Australia, a very high rate because our program has always seriously over-screened women.
    We know that 5 yearly and 2 yearly pap testing carry the same very small chance of benefit, but 2 yearly testing has much more risk and produces a lot more false positives. Evidence based programs are found in Finland and the Netherlands, the former have had their 7 pap test program, 5 yearly from 30 to 60, since the 1960s and have the lowest rates of cc in the world and refer far fewer women for colposcopy/biopsy. Over-treatment and excess biopsies can damage the cervix and lead to miscarriages, premature babies, c-sections, infertility etc
    There is also very little research into the harms that flow from over-treatment – how many women end up having unnecessary cone biopsies? Is prolapse another risk factor after cone biopsy? There are so many unanswered questions, yet if you want to know why some women choose not to have an elective cancer screening test, take your pick, study after study that conclude we’re immature, uneducated, lower class, non-voters etc
    It would never occur to them that some women have simply chosen not to have pap tests, our absolute right, just as many men have chosen not to have prostate screening. (that cancer is much more common, by the way)
    We spend millions to basically worry and harm huge numbers of women and we miss too many of these rare cases with our inefficient excess.

    IMO, this program does not operate in the interests of women and should be reviewed as a matter of urgency by an INDEPENDENT group, someone like the Nordic Cochrane Institute.
    The evidence has moved on and now we see the Dutch about to introduce a new program – 5 hrHPV primary triage tests offered at ages 30,35,40,50 and 60 and ONLY the roughly 5% who are HPV positive and at risk will be offered a 5 yearly pap test. The vast majority of women are HPV negative, not at risk and they will be offered the remaining HPV primary tests. Dutch women are already using a self-test HPV device, the Delphi Screener. (also in use in Singapore and elsewhere) The new Dutch program will save more lives by identifying the roughly 5% at risk and will spare huge numbers of women from a lifetime of unnecessary pap testing and the fairly high risk of potentially harmful over-treatment and excess biopsies.
    Our program is currently under review, but I fear excess will be built into any new program.

    IMO, breast screening adopts the same disgraceful attitudes. IMO, the benefits are inflated, the serious risk of over-diagnosis was suppressed, there is zero respect for informed consent and women are counted like sheep to achieve a govt-set target. Thanks to Assoc Prof Robin Bell, women have heard about over-diagnosis for the first time and the small chance of benefit. The Nordic Cochrane Institute, after criticizing Breast Screen’s brochure here and in other countries, prepared an excellent summary of all of the evidence, it’s at their website and should be offered to every woman – “The Risks and Benefits of Mammograms”.
    Prof Michael Baum, the UK breast cancer surgeon, has also been outspoken about the lack of informed consent in women’s cancer screening – he’s written many great articles.
    I made an informed decision not to have breast screening when I turned 50. Women should also note that clinical breast exams and routine pelvic exams have not been recommended for some time, I’d have refused them anyway. Routine breast exams – there is no evidence of benefit, but they lead to excess biopsies. The routine pelvic exam is of poor clinical value, is not a good screening test for ovarian cancer and carries risk, even unnecessary surgery. The only clinical requirement for the Pill is a blood pressure check and your medical history.
    It’s interesting the American ob-gyn, Dr Carolyn Westhoff, believes the well-woman exam aggressively promoted to women in the States (and many women are coerced into this exam to get the Pill) is partly responsible for their high hysterectomy rates (1 in 3 will have one by age 60) and for the removal of healthy ovaries after false positive pelvic exams.
    Women need to be very careful accepting any information coming from the screening authorities and others with a vested or political interest or pro-screening groups.
    It’s horrible to see the harm and distress caused by our programs and even worse, that most of it was avoidable with screening in responsible hands. (Dr Raffle’s research) (lifetime risk of referral is 77%)
    HPV Today Edition 24, sets out the new Dutch program – registration is free.–ex (2008) Calls to change our program go back a decade or more.
    Pap testing and HPV primary testing is not recommended for those under 30 in countries with evidence based screening – pap testing does not change the tiny incidence or death rate in those under 30, but this age group produce the most false positives, it’s risk for no benefit.
    HPV primary testing is not recommended either as 40% would test positive, most have harmless and transient infections that will clear naturally, only roughly 5% will test positive at age 30, these are the only women who can benefit from a 5 yearly pap test.
    We should have excluded young women from our program many years ago.
    The delay is inexcusable… (Assoc Prof Robin Bell)


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2015 – 2021 Croakey | Website: Rock Lily Design


Follow Croakey